RAPT Therapeutics, Inc.
CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF

Last updated:

Abstract:

Disclosed herein, inter alia, are compounds and methods of use thereof for the modulation of CCR4 activity.

Status:
Application
Type:

Utility

Filling date:

28 Jan 2020

Issue date:

30 Jul 2020